Indication
Alopecia areata
4 clinical trials
5 products
Product
EQ101Clinical trial
An Open-label, Phase 2 Study to Assess the Safety and Efficacy of EQ101 in Adult Subjects With Moderate to Severe Alopecia AreataStatus: Active (not recruiting), Estimated PCD: 2024-03-01
Clinical trial
Clinical Treatment of Alopecia Areata With Stem Cell Educator TherapyStatus: Recruiting, Estimated PCD: 2023-07-30
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of Intravenous BNZ-1 in Patients With Moderate to Severe Alopecia AreataStatus: Withdrawn, Estimated PCD: 2022-11-01
Product
Normal salineProduct
Stem Cell Educator therapyProduct
BNZ-1Clinical trial
Efficacy of Oral Tofacitinib in Moderate to Severe Alopecia Areata, Totalis and Universalis at Tertiary Care Hospital, Karachi.Status: Completed, Estimated PCD: 2024-01-06
Product
Tofacitinib